Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials.

Auteurs

Fernandez-Martinez A, Rediti M, Tang G, Pascual T, Hoadley KA, Venet D, Rashid NU, Spears PA, Islam MN, El-Abed S, Bliss J, Lambertini M, Di Cosimo S, Huobe J, Goerlitz D, Hu R, Lucas PC, Swain SM, Sotiriou C, Perou CM, Carey LA

  • Date de publication

    Maart 2024
  • Type

    Article
  • Tijdschrift

    JAMA Oncol
  • Naam van de onderzoeker

    SOTIRIOU CHRISTOS
  • Hôpital

    Institut Jules Bordet
  • Dienst

    Médecine Oncologique
  • PMID

    38546612
  • DOI

    10.1001/jamaoncol.2023.7304